Monitoring Salivary Levels of Interleukin 1 Beta (IL-1<i>β</i>) and Vascular Endothelial Growth Factor (VEGF) for Two Years of Orthodontic Treatment: A Prospective Pilot Study

<div>Treatment duration of the different treament stages and spacings in the upper and lower jaw (UJ, LJ) before start of alignment and space closure.</div>

Mediators of Inflammation

tab1

Table 1

Table 1: Monitoring Salivary Levels of Interleukin 1 Beta (IL-1<i>β</i>) and Vascular Endothelial Growth Factor (VEGF) for Two Years of Orthodontic Treatment: A Prospective Pilot Study 

Table 1 | Monitoring Salivary Levels of Interleukin 1 Beta (IL-1β) and Vascular Endothelial Growth Factor (VEGF) for Two Years of Orthodontic Treatment: A Prospective Pilot Study 